Hoey Timothy
Insider CIK 1553333 · OMED SVP, Cancer Biology & Co-CSO · TNYA Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-03-05 | 2024-03-06 | 3,300 | $7.00 | $23.1K | 245,346 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2024-02-23 | 2024-02-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2024-02-23 | 2024-02-27 | 12,500 | — | $0 | 248,646 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-21 | 200 | $6.17 | $1.2K | 236,146 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-21 | 6,369 | $5.31 | $33.8K | 236,346 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-02-16 | 2024-02-16 | 4,681 | $5.86 | $27.4K | 242,715 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2023-08-29 | 2023-08-29 | 7,243 | $4.26 | $30.9K | 247,396 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2023-08-16 | 2023-08-18 | 4,007 | $3.81 | $15.3K | 254,639 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 175,000 | — | $0 | 175,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 258,646 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-17 | 30,000 | — | $0 | 228,646 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2022-04-26 | 2022-04-28 | 1,353 | $10.13 | $13.7K | 198,646 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 168,000 | — | $0 | 168,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-04-23 | 2017-04-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-04-23 | 2017-04-25 | 20,000 | — | $0 | 77,225 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 57,225 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 62,936 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2017-01-03 | 2017-01-05 | 12,763 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-01-03 | 2017-01-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2017-01-03 | 2017-01-05 | 12,763 | $1.43 | $18.3K | 73,742 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-01-03 | 2017-01-05 | 12,763 | $7.64 | $97.5K | 60,979 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2016-11-16 | 2016-11-18 | 12,500 | — | $0 | 12,763 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2016-11-16 | 2016-11-18 | 12,500 | $1.43 | $17.9K | 73,479 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-11-16 | 2016-11-18 | 12,500 | $9.89 | $123.6K | 60,979 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 60,979 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 47,181 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.56 | $1.5K | 47,182 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 47,251 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-12-27 | 2015-12-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-06-22 | 2015-06-24 | 5,000 | — | $0 | 25,263 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-06-22 | 2015-06-24 | 5,000 | $26.07 | $130.3K | 49,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-06-22 | 2015-06-24 | 5,000 | $1.43 | $7.2K | 54,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-04-27 | 2015-04-29 | 5,000 | — | $0 | 30,263 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-27 | 2015-04-29 | 3,537 | $25.12 | $88.8K | 52,693 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-27 | 2015-04-29 | 3,350 | $26.20 | $87.8K | 49,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-04-27 | 2015-04-29 | 5,000 | $1.43 | $7.2K | 56,230 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-02-05 | 2015-02-09 | 7,500 | — | $0 | 35,263 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-02-05 | 2015-02-09 | 7,500 | $1.43 | $10.7K | 57,445 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-02-05 | 2015-02-09 | 7,500 | $22.83 | $171.2K | 49,945 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-12-18 | 2014-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-11-05 | 2014-11-07 | 2,500 | — | $0 | 42,763 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-11-05 | 2014-11-07 | 2,500 | $19.51 | $48.8K | 49,945 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-11-05 | 2014-11-07 | 2,500 | $1.43 | $3.6K | 52,445 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-08-05 | 2014-08-07 | 2,500 | — | $0 | 45,263 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-08-05 | 2014-08-07 | 2,300 | $21.61 | $49.7K | 49,543 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-08-05 | 2014-08-07 | 2,500 | $1.43 | $3.6K | 51,843 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-08-05 | 2014-08-07 | 200 | $22.30 | $4.5K | 49,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-05-05 | 2014-05-07 | 2,500 | — | $0 | 47,763 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-05-05 | 2014-05-07 | 2,500 | $1.43 | $3.6K | 51,843 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-05-05 | 2014-05-07 | 2,500 | $26.41 | $66.0K | 49,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 20,000 | — | $0 | 49,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-03-05 | 2014-03-07 | 1,792 | $35.81 | $64.2K | 29,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-02-05 | 2014-02-07 | 5,000 | — | $0 | 50,263 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-02-05 | 2014-02-07 | 4,600 | $30.04 | $138.2K | 29,743 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-02-05 | 2014-02-07 | 400 | $30.85 | $12.3K | 29,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-02-05 | 2014-02-07 | 5,000 | $1.43 | $7.2K | 34,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 5,159 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 3,132 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 5,159 | — | $0 | 29,343 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 3,132 | — | $0 | 24,184 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-07-17 | 2013-07-19 | 14,000 | — | $0 | 14,000 | SEC↗ |